MOH Quote, Financials, Valuation and Earnings

Centene has a net margin of 3.15% compared to Molina Healthcare's net margin of 1.7%. Molina Healthcare's return on equity of 25.77% beat Centene's return on equity of 11.5%.

Molina Healthcare has a consensus price target of $358.46, signalling upside risk potential of 20.91%. On the other hand Centene has an analysts' consensus of $78.92 which suggests that it could grow by 26.05%. Given that Centene has higher upside potential than Molina Healthcare, analysts believe Centene is more attractive than Molina Healthcare.

Molina Healthcare has a beta of 0.543, which suggesting that the stock is 45.712% less volatile than S&P 500. In comparison Centene has a beta of 0.448, suggesting its less volatile than the S&P 500 by 55.17%.

Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Molina Healthcare pays -- of its earnings as a dividend. Centene pays out -- of its earnings as a dividend.

Molina Healthcare quarterly revenues are $10.3B, which are smaller than Centene quarterly revenues of $42B. Molina Healthcare's net income of $326M is lower than Centene's net income of $713M. Notably, Molina Healthcare's price-to-earnings ratio is 15.06x while Centene's PE ratio is 10.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.44x versus 0.21x for Centene. Usually stocks with elevated PS ratios are considered overvalued.

Elevance Health has a net margin of 3.15% compared to Molina Healthcare's net margin of 2.25%. Molina Healthcare's return on equity of 25.77% beat Elevance Health's return on equity of 15.67%.

Molina Healthcare has a consensus price target of $358.46, signalling upside risk potential of 20.91%. On the other hand Elevance Health has an analysts' consensus of $500.87 which suggests that it could grow by 31.55%. Given that Elevance Health has higher upside potential than Molina Healthcare, analysts believe Elevance Health is more attractive than Molina Healthcare.

Molina Healthcare has a beta of 0.543, which suggesting that the stock is 45.712% less volatile than S&P 500. In comparison Elevance Health has a beta of 0.840, suggesting its less volatile than the S&P 500 by 15.968%.

Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Elevance Health offers a yield of 1.71% to investors and pays a quarterly dividend of $1.63 per share. Molina Healthcare pays -- of its earnings as a dividend. Elevance Health pays out 23.3% of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Molina Healthcare quarterly revenues are $10.3B, which are smaller than Elevance Health quarterly revenues of $45.1B. Molina Healthcare's net income of $326M is lower than Elevance Health's net income of $1B. Notably, Molina Healthcare's price-to-earnings ratio is 15.06x while Elevance Health's PE ratio is 13.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.44x versus 0.51x for Elevance Health. Usually stocks with elevated PS ratios are considered overvalued.

Humana has a net margin of 3.15% compared to Molina Healthcare's net margin of 1.63%. Molina Healthcare's return on equity of 25.77% beat Humana's return on equity of 8.1%.

Molina Healthcare has a consensus price target of $358.46, signalling upside risk potential of 20.91%. On the other hand Humana has an analysts' consensus of $296.10 which suggests that it could grow by 10.81%. Given that Molina Healthcare has higher upside potential than Humana, analysts believe Molina Healthcare is more attractive than Humana.

Molina Healthcare has a beta of 0.543, which suggesting that the stock is 45.712% less volatile than S&P 500. In comparison Humana has a beta of 0.553, suggesting its less volatile than the S&P 500 by 44.701%.

Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Humana offers a yield of 1.33% to investors and pays a quarterly dividend of $0.89 per share. Molina Healthcare pays -- of its earnings as a dividend. Humana pays out 17.32% of its earnings as a dividend. Humana's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Molina Healthcare quarterly revenues are $10.3B, which are smaller than Humana quarterly revenues of $29.4B. Molina Healthcare's net income of $326M is lower than Humana's net income of $480M. Notably, Molina Healthcare's price-to-earnings ratio is 15.06x while Humana's PE ratio is 23.67x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.44x versus 0.28x for Humana. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of 3.15% compared to Molina Healthcare's net margin of 6.11%. Molina Healthcare's return on equity of 25.77% beat UnitedHealth Group's return on equity of 14.51%.

Molina Healthcare has a consensus price target of $358.46, signalling upside risk potential of 20.91%. On the other hand UnitedHealth Group has an analysts' consensus of $636.78 which suggests that it could grow by 23.83%. Given that UnitedHealth Group has higher upside potential than Molina Healthcare, analysts believe UnitedHealth Group is more attractive than Molina Healthcare.

Molina Healthcare has a beta of 0.543, which suggesting that the stock is 45.712% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.617, suggesting its less volatile than the S&P 500 by 38.345%.

Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UnitedHealth Group offers a yield of 1.59% to investors and pays a quarterly dividend of $2.10 per share. Molina Healthcare pays -- of its earnings as a dividend. UnitedHealth Group pays out 30.21% of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Molina Healthcare quarterly revenues are $10.3B, which are smaller than UnitedHealth Group quarterly revenues of $99.2B. Molina Healthcare's net income of $326M is lower than UnitedHealth Group's net income of $6.1B. Notably, Molina Healthcare's price-to-earnings ratio is 15.06x while UnitedHealth Group's PE ratio is 33.50x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.44x versus 1.23x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.